near-infrared spectrum. A porcine surgical model was used for this experiment. During data collection, the tissue is exposed to white light, without contrast materials, and the light absorbed or reflected from the tissue is analyzed. Utilizing liquid crystal technology, MCI-E generates real-time wavelength-specific imagery targeting tissue structures, and resulting detections are overlaid onto conventional high definition video. To evaluate detection performance, the contrast between the target tissue and surrounding tissues is quantified with the signal-to-noise ratio (SNR) and area under the ROC curve(AUC).
INTRODUCTION AND OBJECTIVES:
Cryoablation has assumed a growing role in the treatment of both primary, locallyrecurrent and metastatic tumors. However, reporting of procedural complications remains segregated by organ system and physician specialty. We examined urologic and non-urologic device-related adverse events during cryoablation reported to a national administrative database to understand the full spectrum of possible complications.
METHODS: We reviewed reports on cryoablation procedures submitted to the Food and Drug Administration (FDA) Manufacturer and User Facility Device Experience (MAUDE) database between 2015 and 2018. Cases were stratified by solid organ and device malfunction and a standardized MAUDE complication reporting system was used to evaluate direct patient impact. Logistic regression was used to compare complications between renal, prostate, and non-Urologic cases.
RESULTS: 406 cases were identified: 80 renal, 13 prostate, 42 non-urologic, and 271 without specified organ. 306 (75.4%) cases utilized the Galil system. Reports were found to be related to thermal injury, instrument malfunction/failure, computer failure, gas issue, or unrelated to the device. 68 (16.7%) of reported cases were not completed due to the complication. 5 deaths (1.2%) were appreciated (MAUDE 4), 93 (22.9%) major complications (MAUDE 3-4), and 32 (7.9%) minor complications (MAUDE 2). The manufacturer evaluated the device in 305 (75.1%) cases and accepted blame in 159. On univariate analysis, renal cases were associated with decreased odds of being reported with MAUDE 2-4 complications (OR [ 0.449, p[ 0.025) . Conversely, prostate and non-urologic sites were insignificantly predictive of complication level.
CONCLUSIONS: Cryoablation for any tumor, urologic or not, is associated with a diverse set of procedure-related complications. Further study will be required as the usage of cryoablation continues to increase. Urologists performing cryoablation or referring patients for this therapy should be aware to maximize procedural efficacy and safety.
Source of Funding: None

MP20-03 DEVELOPMENT AND VALIDATION OF PATIENT SPECIFIC HYDROGEL KIDNEY PHANTOMS IN PREDICTING PARTIAL NEPHRECTOMY SUCCESS FOR COMPLEX RENAL MASSES
Pratik Gurung*, Rachel Melnyk, Shamroz Farooq, Hani Rashid, Guan Wu, Jean Joseph, Hani Awad, Ahmed Ghazi, Rochester, NY INTRODUCTION AND OBJECTIVES: Models generated from 3D printing technology are limited, by the lack of tissue realism, anatomical accuracy and vascular channels found within surgical target organs, allowing only limited tissue interaction. We present our unique technique, combining 3D printing and hydrogel casting to develop patient-specific kidney phantoms, which can be used as simulation platforms for preoperative rehearsals for cases with complex renal cancer.
METHODS: Model creation: Patient's DICOM files were imported into a segmentation software and converted to STL files to 3D-print injection molds. Individually fabricated tumors and hollow hilar structures were registered within the mold. Hydrogel (PVA) was injected Vol. 201, No. 4S, Supplement, Friday, May 3, 2019 THE JOURNAL OF UROLOGY Ò e283
to create the kidney parenchyma containing the tumor with functional arterial, venous, urine drainage systems. MECHANICAL TESTING: Uniaxial compression: An Instron MTA was used to compress 40 samples from fresh porcine kidneys and compared to 4 different conditions of PVA. Perfusion closure pressures: To replicate the closure forces during renorrhaphy, 5cm longitudinal defects were created in 4 porcine and PVA kidneys. Suture tensions, required to achieve hemostasis and to rip through the parenchyma, were measured. DETERMINING ANATOMICAL ACCURACY: 8 PVA kidney phantoms were reimaged (CT scan) and segmented to generate duplicate sets of STL files that were overlaid to perform a detailed quantitative analysis to determine distance errors in millimeters. Predictive validity: Full procedural rehearsals were performed on models of 8 complex cancer patients (nephrometry score > 8) after surrounding them with relevant organs defined by patient imaging. Warm ischemia time (WIT), estimated blood loss (EBL) and positive surgical margins were measured in the rehearsal and live cases.
RESULTS: Stress-strain relationship for PVA at a concentration of 7% after 2 cycles produced the lowest root mean square error (RMSE[0.0003) compared to fresh porcine kidney tissues. The average RMSE discrepancy between the phantom and patient anatomy were -0.26mm, -0.2mm, 3.10mm, 0.61mm and 3.33mm for kidney parenchyma, tumor, artery, vein and calyx, respectively. Partial nephrectomy was successful in all 8 complex cases after rehearsals. A positive correlation was found in WIT and EBL between the simulated and live surgeries. Rehearsals improved surgeon's confidence in predicting outcomes of these complex cases.
CONCLUSIONS: Software that incorporates patient imaging into 3D printing applications, together with hydrogel molding techniques, are capable of creating human kidney phantoms with authentic anatomical, physical, and functional properties. Application of this versatile and reproducible technique may translate to improved clinical performance.
Source of Funding: None
MP20-04 USABILITY AND TECHNICAL FEASIBILITY EVALUATION OF A TETHERED LAPAROSCOPIC GAMMA PROBE FOR RADIOGUIDED SURGERY IN PROSTATE CANCER: A PELVIC PHANTOM AND PORCINE MODEL STUDY
INTRODUCTION AND OBJECTIVES:
In prostate cancer, radioguided surgery (RGS) is used for sentinel node biopsy (SNB) and holds potential for 99mTc-PSMA-guided surgery of lymph node metastases. Rigid laparoscopic gamma probes currently used for (robotassisted) laparoscopic RGS procedures have limited manoeuvrability and control which restricts nodal identification. To address this a tethered laparoscopic gamma probe was developed (Lightpoint Medical Ltd). The usability and initial performance of this device were assessed in a pelvic phantom and in a porcine model. METHODS: The probe, 35 mm in length and 12 mm in diameter, was tested by 7 urologists using a 3D-printed custom-build pelvic phantom containing anatomical structures and nodal packages of clinical dimensions. To ensure accurate and reproducible gripping, three grip concepts (multi-orientation off centre, multi-orientation cross cable, and single orientation off centre) were designed specifically for use with the da Vinci Prograsp, and tested for ease of gripping and handling on a 3-ranked system. Four graphic user interfaces (GUIs) were also evaluated.
The favoured grip and GUI was then evaluated in a porcine model containing 4 vials of clinically representative sentinel node volumes (0.2 ml) and 99mTc activities (range 33 -134 kBq). Prior to surgery the vials were placed on the skin of the lower abdomen, and locations monitored by CT scanning. Manual laparoscopic surgery was performed by two urologists and 1 nuclear medicine physician tasked to identify the vials in vivo by scanning the pelvic peritoneum. Upon completion participants were asked to score the overall design on a 5-point scale.
RESULTS: The multi-orientation off-centre grip was favoured over the other two grip designs (average rank: 1.1 vs 2.4 vs 2.4), and considered most versatile. In the porcine study, all activity concentrations could be successfully detected. All 3 participants identified the 134 kBq vials, while the 65 and 33 kBq vials were identified by 2 and 1 participants, respectively. All 3 participants found the GUI simple and easy to interpret, and the overall design of the probe was scored as 4.2/5. CONCLUSIONS: The usability studies demonstrate that the tethered laparoscopic gamma probe meets the usability requirements for manual laparoscopic and robotic prostate cancer surgery. Learnings from these studies greatly influenced the design of the probe and its GUI, and clinical studies to evaluate the performance of this probe in SNB and 99mTc-PSMA RGS of LN metastases are scheduled for 2019. The aim of this feasibility study is to avail ourselves of a potential cohort derived from approximately 130,000 patients who filed lawsuits against mesh manufacturers. We aim to evaluate the prevalence, severity, diagnostic and treatment outcomes of SMUS complications. Ultimately, the data may be used to estimate the proportion of litigation cases with proven meshrelated complications and the nature of mesh complications.
METHODS: This is a retrospective observational study of a deidentified database extracted from the medical records of mesh litigation cases that have been reviewed by at least one expert witness who had access to all available medical records, including expert witness reports for both the plaintiff and defense. A panel, consisting of two expert witnesses each for the plaintiff and defense and a neutral "tiebreaker" was convened and devised criteria defining definite, possible and non-mesh complications. Disagreement between experts was resolved by the tiebreaker who had access to the deidentified records. Plaintiffs with insufficient records were excluded. Recorded definite and possible complications are listed in Table 1 . The following information was extracted: type of synthetic sling, time interval between implantation and first complication, number and type of complications, number of surgeries to treat complications from implantation surgery and outcome of treatment from each complication at the time of the last record.
RESULTS: 47 cases were reviewed and 2 excluded because of incomplete medical records. Mean age at surgery was 49 (range 28 -76) years old. The mean interval between SMUS implantation to the first definite and possible complication is 27 (SD 29) and 17 (SD 23) months, respectively (range 0 -120 months). Table 1 . depicts other results.
CONCLUSIONS: Patients who have filed lawsuits against mesh manufacturers may provide a rich database for clinical research because complete medical records are usually available. In this feasibility study appropriate medical records were available in 96% of patients of whom 73% had definite and 24% had possible mesh
